| Dr Irina Digilova, MD | |
|
6302 West Broadway Street, Suite 230, Pearland, TX 77581-7828 | |
| (281) 529-6242 | |
| (281) 741-4104 |
| Full Name | Dr Irina Digilova |
|---|---|
| Gender | Female |
| Speciality | Psychiatry |
| Experience | 40 Years |
| Location | 6302 West Broadway Street, Pearland, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255447512 | NPI | - | NPPES |
| 148028704 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | L3282 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Harris Health System | Houston, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Baylor College Of Medicine | 8224941265 | 684 |
News Archive
A balloon angioplasty device that sucks up dangerous plaque debris could trigger a "paradign shift" in how physicians treat peripheral artery disease, researchers write in the current issue of Endovascular Today.
The COVID-19 pandemic is a catalyst to accelerate the adoption of technology-enabled patient care for epilepsy, according to a new study published in Epilepsia.
A research abstract that will be presented on Tuesday, June 9, at SLEEP 2009, the 23rd Annual Meeting of the Associated Professional Sleep Societies, is the first demonstration of a specific neurochemical abnormality in adults with primary insomnia (PI), providing greater insight to the limited understanding of the condition's pathology.
Researchers have designed a new class of TMPRSS2 inhibitors that have shown broad antiviral activity against coronaviruses, including the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
› Verified 5 days ago
| Entity Name | Baylor College Of Medicine |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053352914 PECOS PAC ID: 8224941265 Enrollment ID: O20031106000562 |
News Archive
A balloon angioplasty device that sucks up dangerous plaque debris could trigger a "paradign shift" in how physicians treat peripheral artery disease, researchers write in the current issue of Endovascular Today.
The COVID-19 pandemic is a catalyst to accelerate the adoption of technology-enabled patient care for epilepsy, according to a new study published in Epilepsia.
A research abstract that will be presented on Tuesday, June 9, at SLEEP 2009, the 23rd Annual Meeting of the Associated Professional Sleep Societies, is the first demonstration of a specific neurochemical abnormality in adults with primary insomnia (PI), providing greater insight to the limited understanding of the condition's pathology.
Researchers have designed a new class of TMPRSS2 inhibitors that have shown broad antiviral activity against coronaviruses, including the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Irina Digilova, MD 6302 West Broadway Street, Suite 230, Pearland, TX 77581-7828 Ph: (281) 529-6242 | Dr Irina Digilova, MD 6302 West Broadway Street, Suite 230, Pearland, TX 77581-7828 Ph: (281) 529-6242 |
News Archive
A balloon angioplasty device that sucks up dangerous plaque debris could trigger a "paradign shift" in how physicians treat peripheral artery disease, researchers write in the current issue of Endovascular Today.
The COVID-19 pandemic is a catalyst to accelerate the adoption of technology-enabled patient care for epilepsy, according to a new study published in Epilepsia.
A research abstract that will be presented on Tuesday, June 9, at SLEEP 2009, the 23rd Annual Meeting of the Associated Professional Sleep Societies, is the first demonstration of a specific neurochemical abnormality in adults with primary insomnia (PI), providing greater insight to the limited understanding of the condition's pathology.
Researchers have designed a new class of TMPRSS2 inhibitors that have shown broad antiviral activity against coronaviruses, including the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
› Verified 5 days ago
Tiffany Cossey, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 10905 Memorial Hermann Dr Ste 111, Pearland, TX 77584 Phone: 281-929-4727 Fax: 281-929-4728 | |
Dr. Rebecca Helena Maxwell, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 3518 Brandemere Dr, Pearland, TX 77584 Phone: 713-598-6265 Fax: 281-485-9089 | |
Leah Quezada Kolar Onoja, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 7501 Fite Rd, Pearland, TX 77584 Phone: 281-997-5515 | |
Dr. Chiyyarath V Sathees, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2225 County Road 90, Suite 201 G, Pearland, TX 77584 Phone: 832-654-4390 Fax: 281-265-2751 | |
Lynette M Gogol, D.O. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2225 County Rd 90, Suite 107, Pearland, TX 77584 Phone: 281-485-2337 Fax: 281-485-2985 | |
Dr. Kathleen H. Eberle, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 10905 Memorial Hermann Dr, Ste 115, Pearland, TX 77584 Phone: 713-947-3100 Fax: 713-704-1796 |